Aims Pre-infarction angina is associated with better outcome after myocardial infarction. The aim of this study was to assess whether pre-infarction angina is associated with decreased no-reflow after coronary recanalization.
Introduction
Brief episodes of myocardial ischaemia prior to experimental infarction are associated with decreased infarct size and improved wall motion recovery [1, 2] . In humans, pre-infarction angina is associated with improved prognosis after acute myocardial infarction [3] [4] [5] [6] . Several mechanisms may explain this benefit [5] , such as enhanced collateral circulation towards the ischaemic myocardium, increased sensitivity to thrombolysis [6] , or myocardial ischaemic preconditioning [3, 4, 7] . Reperfusion-induced vascular stunning is markedly reduced by experimental pre-infarction ischaemia [8, 9] . Improved perfusion of the area at risk after coronary recanalization may be related to ischaemic preconditioning of the vasculature. In humans, vascular injury following ischaemia and reperfusion results in myocardial no-reflow (reduced myocardial perfusion despite complete epicardial coronary recanalization) [10] . Preinfarction angina may reduce no-reflow by protecting against ischaemia/reperfusion-induced microvascular injury.
We tested this hypothesis by assessing myocardial perfusion in the area at risk in patients with and without pre-infarction angina, using myocardial contrast echocardiography during coronary angiography, after recanalization of the infarct-related artery. This method has been previously used to assess myocardial perfusion [11] [12] [13] , including during acute myocardial infarction [14] [15] [16] [17] .
Methods

Inclusion criteria
We studied patients admitted with ongoing acute anterior myocardial infarction less than 6 h after symptom onset and with angiographically proven complete patency (TIMI grade 3 flow) of the left anterior descending artery in the acute phase. The diagnosis of acute myocardial infraction was based on typical chest pain lasting more than 30 min, resistant to sublingual or intravenous nitrates, and associated with ST segment elevation d0·2 mV in at least two contiguous leads. The diagnosis was confirmed in every case by elevation of creatine kinase to at least twice the normal value. Patients were not eligible if they were under 18 or over 80, or had cardiogenic shock or haemodynamic instability, a history of coronary bypass surgery, previous myocardial infarction, or more than 50% stenosis of the main left coronary artery.
Medical management of the acute phase of myocardial infarction
All the patients underwent coronary angiography on admission. Flow in the infarct-related artery and angiographic collateral flow were graded using the TIMI and Rentrop scoring systems, respectively [18, 19] . Emergency PTCA was attempted when flow in the infarct-related artery was <TIMI 3. All patients received aspirin (d250 mg orally or intravenously) and a 5000 IU bolus of intravenous heparin followed by a continuous infusion of 300 to 500 IU . kg 1 , titrated to maintain the activated partial prothrombin time between 2 and 3. Patients who underwent coronary angioplasty received a second bolus of 5000 IU of heparin. Other treatments (nitrates, beta-blockers, angiotensin-converting enzyme inhibitors), and stent implantation, were used as necessary.
Definition of pre-infarction angina
Pre-infarction angina was prospectively defined as at least one episode of typical chest or left arm or jaw pain, either at rest or during exercise, less than 7 days before acute myocardial infarction. The latter was defined by the onset of chest pain lasting more than 30 min leading to the hospital admission.
Study design
In order to ensure that the angiographic TIMI 3 flow was sustained, myocardial contrast echocardiography was performed 10 to 15 min after documentation of TIMI grade 3 flow in the infarct-related artery. In addition, persistence of TIMI 3 flow patency was further verified by intracoronary dye injection immediately prior to performing myocardial contrast echocardiography. It was repeated before discharge (8 2 days) in 21 patients (12 with and nine without pre-infarction angina). Baseline 2D echocardiography was performed acutely (before myocardial contrast echocardiography) in all patients and was repeated at day 42 in 18 patients (12 with and six without pre-infarction angina). Left ventricular radionuclide angiography was performed 5 to 10 days (mean 7 2) after myocardial infarction in 20 cases (12 with and eight without pre-infarction angina) and on day 42 in 19 cases (11 patients with and eight without pre-infraction angina). All patients underwent repeat coronary angiography before discharge. All gave informed consent to participation in the study. The protocol was approved by the institutional ethics committee on human research.
Baseline 2D echocardiography
Baseline 2D echocadiography was performed with the patient lying supine, using a 2·5 MHz transducer fitted to a dedicated echocardiographic system (HewlettPackard Sonos 1500). Images were recorded on S-VHS tapes and analysed off-line by two experienced observers blinded to clinical data. Discrepancies were resolved by consensus reading. Four views were used: parasternal long and short-axis (at the level of the papillary muscle) and apical two-and four-chamber views. The left ventricle was divided into 16 segments, as described by the American Society of Echocadiography [20] . In each segment, wall motion was graded as: 1 for normal, 2 for hypokinesia, 3 for akinesia or dyskinesia. A regional wall motion score in the area at risk was computed as the sum of the wall motion grades for each segment (in the initially hypo-or akinetic area) divided by the total number of segments visualized (in the same area).
Myocardial contrast echocardiography
Myocardial contrast echocardiography was performed after obtention of TIMI grade 3 flow in the infarctrelated artery, using the same echocardiographic system. Three-millilitre aliquots of sonicated ioxaglate (Hexabrix 320, Guerbet, France) were consecutively injected into both the left and right coronary arteries; one injection of sonicated ioxaglate was used for each echocardiographic view. Ioxaglate was sonicated as previously described [21] . Image recording was started 10 s before contrast injection and continued until contrast enhancement disappeared. The echocardiographic views, myocardial segmentation, and image analysis were similar to those used for baseline 2D echocardiography. For each segment, a myocardial perfusion
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grade was defined as: 0 for no contrast; 0·5 for incomplete or heterogenous contrast; 1 for homogenous and complete contrast. When the segmental perfusion grade was not the same in the left and right coronary arteries injections, the highest grade was assigned to the segment concerned. A mean perfusion score was calculated for each patient as the sum of the perfusion grades in the hypo-or a-or dyskinetic segments (which were considered as the area at risk) divided by the number of segments in the same area, as previously described. No-reflow was defined in binary fashion as a mean perfusion score c0·5. The Kappa value for inter-observer agreement for all echographic data was 0·71.
Radionuclide angiography
After in vivo erythrocyte labelling with 110 MBq (30 mCi) of 99m-technetium, gated equilibrium radionuclide studies were acquired in the left anterior oblique projection with the best septal visualization (between 30 and 40 ). Sixteen images (64 64 matrix, zoom value of 2·0) were acquired per cardiac cycle. Gating was triggered by the ECG R wave, with a window of 20% centred on the average cardiac cycle length until a total count of 400 Kc per image was reached. Acquisition was computed by using a standard softward package automatically delineating two regions of interest around the left ventricle. Regions of interest can be manually corrected with the help of Laplacian, amplitude or phase images. Using this software, normal left ventricular ejection fraction values ranged between 55 and 75%, and inter-observer reproducibility was r=0·97.
Statistical analysis
All continuous values are expressed as mean standard deviation. Comparisons between groups were made using Student unpaired t-test for continuous variables, and chi-squre test for discrete variables. P values <0·05 were considered significant.
Results
Twenty three patients with anterior myocardial infarction were enrolled in the study (Table 1 ). All had angiographic documentation of complete restoration of patency of the infarct-related artery in the acute phase. Eighteen of the 23 patients underwent primary or rescue PTCA; four were successfully treated with t-PA, with angiographically proven TIMI 3 patency of the infarctrelated artery 90 min after treatment (two patients with and two without pre-infarction angina), and one underwent spontaneous recanalization of the infarct-related artery (Table 2 ). Repeat coronary angiography (8 2 days after admission) showed sustained TIMI grade 3 patency of the infarct artery in all the patients.
During the week preceding acute myocardial infarction, 14 of the 23 patients had pre-infarction angina while nine had not. In the patients with pre-infarction angina, seven patients had had angina for more than 1 week, including one patient with known coronary artery disease. None of the patients had a history or evidence of previous myocardial infarction in the territory of the ongoing myocardial infarction. As shown in Table 2 , baseline characteristics were similar between groups. Patients with pre-infarction angina were slightly younger than patients without pre-infarction angina. There was a non-significant trend towards more extensive angiographic coronary artery disease and increased angiographic evidence of collateral circulation in patients without pre-infarction angina. The size of the area at risk, as assessed from the number of dyssynergic segments, and the regional wall motion score on baseline 2D echocardiography, were similar in the two groups.
Myocardial perfusion after recanalization
On myocardial contrast echocardiography performed during the acute phase (12 3 minutes after TIMI 3 flow documentation), the mean perfusion score in the area at risk was higher in patients with pre-infarction angina than in patients without pre-infarction angina (0·72 0·19 vs 0·53 0·22, P=0·04) (Fig. 1) . No-reflow, defined in binary fashion (mean perfusion score c0·5), was observed in two patients with pre-infarction angina as compared to five patients without pre-infarction angina (14% and 56% respectively P=0·04).
At repeat myocardial contrast echocardiography, the mean perfusion score in the area at risk was still higher in patients with than without pre-infarction angina (0·87 0·11 vs 0·69 0·26, P=0·04) (Fig. 1) . The increase in mean perfusion score between day 0 and day 8 was similar in the two groups (+0·16 0·17 vs 0·17 0·39, ns). The incidence of no-reflow was different between the two groups: it was observed in none of the 
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pre-infarction angina patients with and in three patients without pre-infarction angina (0 vs 33%, P=0·03). An example of no-reflow is shown Fig. 2 .
Left ventricular global and regional
functional recovery (Table 3) The changes in radionuclide left ventricular ejection fraction differed markedly between groups, improving from day 8 to day 42 in patients with pre-infarction angina, and deteriorating in patients without preinfarction angina (+5·8 8·1 vs 3·3 4·6%, respectively; P=0·01) (Fig. 3) . Echocardiographic regional wall motion scores in the area at risk showed better recovery in patients with than in those without pre-infarction angina ( 0·61 0·39 vs 0·24 0·17, P=0·04).
Discussion
The main result of this study is that recent pre-infarction angina appears to protect the microvasculature in the area at risk after myocardial infarction, and is associated with improved left ventricular functional recovery. Pre-infarction angina is associated with a better prognosis: short periods of myocardial ischaemia before sustained coronary occlusion are associated with a smaller infarct size, improved left ventricular function, and a significantly lower risk of in-hospital death [1] [2] [3] [4] [5] [6] 22] . The cardioprotective role of pre-infarction angina may be explained by several mechanisms [5] , such as opening of collateral circulation [23] , increased sensitivity to thrombolysis [6] , or myocardial pre-conditioning [3, 7] . Preconditioning may also protect the coronary arteriolar endothelium from ischaemia-reperfusion injury [8, 9] . Such microvascular preconditioning would result in decreased no-reflow and increased myocardial perfusion after coronary recanalization. This hypothesis has been tested in experimental models but with contradictory results [24] [25] [26] . Given the close relationship between myocardial perfusion after infarct-related artery recanalization and left ventricular functional recovery [14, [27] [28] [29] [30] [31] [32] , pre-infarction angina, by increasing myocardial perfusion, might limit infarct size and post-ischaemic contractile dysfunction [3, 33] . Using myocardial contrast echocardiography, a validated method for the assessment of myocardial perfusion [13, 14, 28, 34, 35] , we found that pre-infarction angina was associated with improved myocardial perfusion in the area at risk and decreased no-reflow, relative to patients without pre-infarction angina. Although part of the microvascular dysfunction observed in acute myocardial infarction may be transient [36, 37] , this difference is sustained 8 days after acute myocardial infarction. Since increased sensitivity to thrombolysis can be ruled out, and as all patients were successfully recanalized (TIMI 3 flow), decreased acute no-reflow in patients with preinfarction angina probably reflects preserved microvascular integrity. Although angiography has limitations in the assessment of collateral circulation [35] , there was no difference in angiographically assessed collateral circulation between the two groups. In fact, there was a slight but non-significant trend towards higher collateral circulation in patients without pre-infarction angina. Preservation of microvascular integrity is therefore a strong candidate mechanism for the protective effect of pre-infarction angina, although a role of myocardial preconditioning in the better functional recovery cannot be ruled out.
There are several limitations to this study. Semiquantitative myocardial contrast echocardiography relies on echocardiographic image quality, which is difficult to optimize in the catheterization laboratory and is limited by the variability in contrast intensity related to hand-made sonicated contrast. Furthermore, there is no accepted definition for pre-infarction angina; indeed, four different definitions were used in four previous studies [3] [4] [5] [6] . Obviously, all clinical definitions of pre-infarction angina will miss silent ischaemia, which would also be expected to confer protection. We also used the extent of dyssynergic segments as the extent of the area at risk. However, it is possible that the echographic dyssynergic area may overestimate the size of the area at risk, because of the existence of a border zone including hypokinetic but non-ischaemic segments. So, in our study, the perfusion score was calculated in the dyssynergic segments rather than in the area at risk. Finally, the number of patients included was small.
In conclusion, the present study shows that preinfarction angina is associated with decreased no-reflow in patients with anterior infarctions and recanalization of the infarct vessel, and with superior recovery of regional and global left ventricular function. Such decreased no-reflow may reflect preconditioning of the microvasculature by pre-infarction angina and provides an additional hypothetical mechanism for the clinical benefit of pre-infarction angina.
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